NCT04726735
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
- Locations
-
- Centre Hospitalier Universitaire de Bordeaux Talence, France
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,957 public trials
633 recruiting studies
Urologic Neoplasms trial results
NCT03977831
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
- Locations
-
- Department of Urology, Rigshospitalet Copenhagen, Denmark
NCT04723121
- Conditions
- Bladder Cancer, Disease Attributes, Disease Progression, +14 more
- Locations
-
- Urology and Nephrology Center Al Mansurah, DK, Egypt
NCT04184232
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus Minsk, Belarus
NCT02197897
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Baylor College of Medicine Houston, Texas, United States
- Harris Health System Houston, Texas, United States
NCT01665703
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
Completed
Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States
NCT00340457
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- University of Illinois at Chicago Chicago, Illinois, United States
- Wayne State University Detroit, Michigan, United States
NCT04683536
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
- Locations
-
Not specified
NCT03955393
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
- Locations
-
- IRCCS San Raffaele Milan, Italy
NCT01152801
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Novartis Investigative Site Wuhan, Hubei, China
- Novartis Investigative Site Nanjing, Jiangsu, China
- Novartis Investigative Site Beijing, China
- Novartis Investigative Site Beijing, China